Jeff Skinner

National Institutes of Health

Papers

1

Total Citations

39

H-Index

1

About

Jeff Skinner is a leading malaria researcher whose work focuses on the immunology and epidemiology of *Plasmodium falciparum* infection, with a particular emphasis on vaccine evaluation and host-parasite interactions. His most cited study, "RTS,S Vaccination Is Associated With Serologic Evidence of Decreased Exposure to *Plasmodium falciparum* Liver- and Blood-Stage Parasites," provides critical insight into how the RTS,S vaccine—the world’s first licensed malaria vaccine—modulates exposure to both liver- and blood-stage parasites. By demonstrating that vaccinated individuals show serologic evidence of reduced parasite exposure, Skinner’s work helps explain the partial protection conferred by RTS,S and informs strategies for improving next-generation vaccines. His research bridges fundamental immunology and translational public health, offering a clearer understanding of how antibody responses to the circumsporozoite protein correlate with protection. With nearly 40 citations on this landmark paper, Skinner’s contributions are shaping the scientific dialogue around malaria vaccine development. His findings are essential reading for students and researchers interested in vaccine-induced immunity, malaria control, and the complex dynamics between host and pathogen.

Research Focus

Key Achievements

1
H-Index
1
Papers
39
Total Citations
39
Avg Citations/Paper
🏆 Most Cited Paper
RTS,S Vaccination Is Associated With Serologic Evidence of Decreased Exposure to Plasmodium falciparum Liver- and Blood-Stage Parasites*
39 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: National Institutes of Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago